Postoperative intensity-modulated radiation therapy in cervical cancer trial

Not Applicable

Recruiting

• Conditions: Diseases of The genitoruinary system

• Registration Number: KCT0004700
• Lead Sponsor: Samsung Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

1) histological confirmed cervical cancer
2) radical hysterectomy and pelvic lymph node dissection was done
3) indicated as below in pathology (more than one)
- tumor size =4cm
- lymphovascular invasion
- cervical stromal invasion =1/2
4) age 20-70
5) ECOG 0-1
6) granulocyte =1.0 x 103/µl, platelet =30 x 103/µl, hemoglobin =10 g/dl
7) If the patient voluntarily completes the consent form

Exclusion Criteria

1) pelvic lymph node metastasis
2) distant metastiss (retroperitoneal lymph node metastasis)
3) resection margin positive
4) parametrial invasion
5) previous pelvic radiohterapy
6 more than 3 months after radical hysterectomy
7 serious acute illness
8 neoadjuvant chemotherapy
9 other cancer history except for thyroid cancer, skin cancer, cervix is situ

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
more than acute grade 3 toxicity

Secondary Outcome Measures

Name	Time	Method
more than chronic grade 3 toxicity